Summary of Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2013

Summary of Significant Accounting Policies

Schedule of the Company's net sales by medical indication

(In thousands)	Three Months Ended September 30,
Medical Indication	2013		2012
Antibiotic	$	3,375	$	1,689
Cardiovascular	4,524		7,100
Gallstone	1,366		1,578
Glaucoma	1,455		1,373
Gout	2,053		165
Migraine	2,715		1,249
Obesity	1,131		1,310
Pain Management	5,218		5,532
Thyroid Deficiency	20,027		13,637
Other	3,965		1,661
Total	$	45,829	$	35,294

Summary of products which accounted for at least 10% of net sales

	2013		2012
Product 1	44	%	39	%
Product 2	6	%	10	%
Product 3	4	%	10	%

Summary of customers which accounted for at least 10% of net sales

	2013		2012
Customer A	16	%	17	%
Customer B	14	%	11	%
Customer C	11	%	10	%
Customer D	8	%	10	%